Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms.
about
Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumptionRisk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and societyDevelopments in renal pharmacogenomics and applications in chronic kidney diseaseDifferential Gene Expression across Breed and Sex in Commercial Pigs Administered Fenbendazole and Flunixin MeglumineImplications of sleep and energy drink use for health disparitiesCoffee consumption and incidence of lung cancer in the NIH-AARP Diet and Health StudyMaternal smoking, xenobiotic metabolizing enzyme gene variants, and gastroschisis riskCumulative neurobehavioral and physiological effects of chronic caffeine intake: individual differences and implications for the use of caffeinated energy productsGene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2.Investigation of the major cytochrome P450 1A2 genetic variant in a healthy Tibetan population in China.Genetics of caffeine consumption and responses to caffeine.Sulfaphenazole and α-naphthoflavone attenuate the metabolism of the synthetic cannabinoids JWH-018 and AM2201 found in K2/spice.Influence of environmental and genetic factors on CYP1A2 activity in individuals of South Asian and European ancestry.Association of coffee drinking with all-cause mortality: a systematic review and meta-analysis.Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.Perceived stress, reproductive hormones, and ovulatory function: a prospective cohort studyCYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine.Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.Caffeinated beverage intake and reproductive hormones among premenopausal women in the BioCycle Study.Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes.PharmGKB summary: very important pharmacogene information for CYP1A2.Caffeine Cytochrome P450 1A2 Metabolic Phenotype Does Not Predict the Metabolism of Heterocyclic Aromatic Amines in Humans.Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.Activation of aflatoxin B1 by expression of human CYP1A2 polymorphisms in Saccharomyces cerevisiae.Caffeine and diuresis during rest and exercise: A meta-analysis.Serum caffeine and paraxanthine concentrations and menstrual cycle function: correlations with beverage intakes and associations with race, reproductive hormones, and anovulation in the BioCycle StudyGene expression and immunochemical localization of major cytochrome P450 drug-metabolizing enzymes in bovine nasal olfactory and respiratory mucosa.Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2.CYP1A2, GSTM1, and GSTT1 polymorphisms and diet effects on CYP1A2 activity in a crossover feeding trial.Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals.Epigenetic and microRNA-dependent control of cytochrome P450 expression: a gap between DNA and protein.Cytochrome P450 variations in different ethnic populations.Gene-environment interactions of selected pharmacogenes in arterial hypertension.Cytochrome P450 pharmacogenetics in African populations.Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia.Blood pressure in relation to coffee and caffeine consumption.A Prospective Investigation of Coffee Drinking and Bladder Cancer Incidence in the United States.Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date.Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior.
P2860
Q21144958-31285410-3E30-4B83-BFBD-F68DE9EB75C9Q24289220-ED1446E6-5E9D-422A-9E73-A7279308F852Q26999279-8307D1A9-F7AD-40A1-90CD-8B490B1DEB57Q27318232-406348EB-C07C-485B-A593-E80D9A0B3350Q28384117-28BC82F8-DBF0-49A8-ADA3-429DEF23FF5DQ28387946-C07E5D5A-EAD3-48D4-BFC1-95CCCDD89C34Q28391030-77A74F99-F6C8-474C-BE09-99375CCF62D2Q28392222-68A685D9-A30D-4FB5-AD75-748380420200Q33782664-BA985020-FDCE-4733-BA98-0423EB55B060Q33828034-525FB195-2E01-43C3-8D4C-22F3F442D3FAQ34119748-667B1443-40AB-4B43-B599-87BD7B7FBF0AQ34133537-D74C550E-A429-4F9E-AD7B-D4A4131494F3Q34297580-061AC719-CDDC-4AA8-8018-877F2EE14CD2Q34432190-62C7B1B4-E141-472C-9994-650038B15A32Q35015993-45CE7F8D-08F0-4B7F-BD72-3940F02B50C5Q35043126-4AEA7618-087B-4219-8A4D-E8DA3A65B4A9Q35098697-2111AC96-513B-4481-842F-C8A4E92CF300Q35210306-452DADE3-11AA-497E-B107-6700525FECCAQ35677309-D248A6E9-1C09-4806-9784-051379516BA8Q35718630-04936A01-2EEC-4B08-85EF-7BE0EACFCAC2Q35940452-5C530564-07A4-4538-8602-BA3DF4FB7F01Q36063995-2160C3B9-4E31-4EE7-A1D8-F6333DFE6E85Q36285918-5A75A79A-0CD8-4DC1-9791-9D5610BB1890Q36450003-39C5D53C-D500-4EB0-8EDC-D3292A402B20Q36497597-902FAC45-3265-4BA3-85E8-8A72B5C46E8CQ37034587-4E4738BB-15AC-49F9-B84E-3459B22EEA47Q37145892-02513240-30F9-4191-A5F4-0C15E53AC771Q37378059-B3CBC423-1A29-4CB1-AB93-1607A85489D0Q37442320-88B83609-78F1-4F25-8DA2-1DA53E9F3581Q37538683-E7D941A7-8BD7-4920-83F7-4473E9ABE6CBQ37551896-42DB8D98-CE4A-4EAC-BD72-5887C88A168BQ37979866-476392F7-2F85-4057-8CD7-8ADE6ADEB01EQ38066959-B54E4C1B-195F-496F-9ADF-EA41A68C59E3Q38099372-05208270-C478-411A-80D5-9D6C8C3D694EQ38103885-E17AD51E-88D1-46C4-B202-7B3D835EB443Q38236743-C65F4520-7EF4-43C9-883E-933C5A718B5CQ38646407-B9899E65-08A7-4C24-AEE4-2E1E4869BBDFQ39146738-688C8587-2669-4118-9B71-085B94155FCAQ39429441-E3395B88-6CE5-4E26-854B-845508589E0FQ40554461-285E7BA0-900F-4812-8B12-CB1CCF1FE929
P2860
Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Variation in CYP1A2 activity a ...... ors and genetic polymorphisms.
@en
Variation in CYP1A2 activity a ...... ors and genetic polymorphisms.
@nl
type
label
Variation in CYP1A2 activity a ...... ors and genetic polymorphisms.
@en
Variation in CYP1A2 activity a ...... ors and genetic polymorphisms.
@nl
prefLabel
Variation in CYP1A2 activity a ...... ors and genetic polymorphisms.
@en
Variation in CYP1A2 activity a ...... ors and genetic polymorphisms.
@nl
P2860
P356
P1433
P1476
Variation in CYP1A2 activity a ...... ors and genetic polymorphisms.
@en
P2093
Arzu Gunes
Marja-Liisa Dahl
P2860
P304
P356
10.2217/14622416.9.5.625
P577
2008-05-01T00:00:00Z